Stay updated on SKI-G-801 Dose Study in AML Clinical Trial

Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.2 to v3.8.0. The study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:49:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice announces NIH website changes and says federal agencies are shifting from the term “Artificial Intelligence” to “Super Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:12:03.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T15:10:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The displayed site revision advances from v3.7.0 to v3.7.1 while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message instead of its study content, with a Home link.
    Difference
    0.6%
    Check dated 2026-10-04T16:15:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content; the detailed study information and related sections appear to be removed or inaccessible, and the standard site footer is shown.
    Difference
    17%
    Check dated 2026-09-20T20:04:10.000Z thumbnail image

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.